The safe and effectiveness of continuous cisternal irrigation with artificial magnesium solution in patient with aneurysmal subarachnoid hemorrhage.

The safe and effectiveness of continuous cisternal irrigation with artificial magnesium solution in patient with aneurysmal subarachnoid hemorrhage. - Effects of continuous intracisternal magnesium injection for vasospam in subarachnoid hemorrhage.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015760

Enrollment

Registered

2014-11-26

Start date

2008-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subarachnoid hemorrhage

Interventions

continuous cisternal irrigation with artificial magnesium solution ordinary treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aneurysmal subarachnoid hemorrhage 2. Patients treated by clipping via craniotomy within 72 hours after SAH 3. Patients classified as WFNS SHA Grade 1 to 4 4. Patients classified as Fisher CT group 2 and 3

Exclusion criteria

Exclusion criteria: 1. Age older than 80 years 2. Patients with severe surgical complication 3. Patients with pregnancy 4. Patients with malignant tumor, liver failure, and renal failure 5. Patients judged improper candidate by doctor

Design outcomes

Primary

Measure	Time frame
Functional outcome at 3months after onset (modified Rankin Scale, Glasgow outcome scale)	—

Secondary

Measure	Time frame
1. chronological changes of Mg2+ concentration in serum and CSF 2. infarction caused by vasospasm 3. MCA velocity measured by TCD 4. Angiographical vasospasm on digital subtraction angiography	—

Countries

Japan

Contacts

Public ContactTakuji Yamamoto

Junetndo University Shizuoka Hospital Department of Neurosurgery

tyamamoto@med-juntendo.jp055-948-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026